Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry

AIMS: Digoxin is included in some heart failure (HF) guidelines but controversy persists about the true role for and impact of treatment with this drug, particularly in the absence of atrial fibrillation (AF). The aim of this study was to assess the association between clinical characteristics and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapelios, Chris J, Lund, Lars H, Benson, Lina, Dahlström, Ulf, Rosano, Giuseppe M C, Hauptman, Paul J, Savarese, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716867/
https://www.ncbi.nlm.nih.gov/pubmed/34921603
http://dx.doi.org/10.1093/ehjcvp/pvab079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716867/
https://www.ncbi.nlm.nih.gov/pubmed/34921603
http://dx.doi.org/10.1093/ehjcvp/pvab079

Ejemplares similares